A similar 12-chemokine gene signature (CCL2, CCL3, CCL4, CCL5, CCL8, CCL18, CCL19, CCL21, CXCL9, CXCL10, CXCL11, and CXCL13) was derived through metagene analysis and correlated with enhanced patient survival in colorectal cancer (146) independent of tumor stage, location, microsatellite stability status, or treatment. This evidence concerns the gene CXCL11 and colorectal cancer.